Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genasys (GNSS) Asset Writedowns and Impairment (2017 - 2025)

Historic Asset Writedowns and Impairment for Genasys (GNSS) over the last 14 years, with Q4 2025 value amounting to $26000.0.

  • Genasys' Asset Writedowns and Impairment fell 6438.36% to $26000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $404000.0, marking a year-over-year increase of 96315.79%. This contributed to the annual value of $451000.0 for FY2025, which is 1117500.0% up from last year.
  • As of Q4 2025, Genasys' Asset Writedowns and Impairment stood at $26000.0, which was down 6438.36% from $197000.0 recorded in Q3 2025.
  • Over the past 5 years, Genasys' Asset Writedowns and Impairment peaked at $197000.0 during Q3 2025, and registered a low of -$135000.0 during Q3 2024.
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $73500.0 (2024), whereas its average is $69400.0.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first tumbled by 22162.16% in 2024, then skyrocketed by 25384.62% in 2025.
  • Genasys' Asset Writedowns and Impairment (Quarter) stood at $26000.0 in 2021, then skyrocketed by 76.92% to $46000.0 in 2022, then decreased by 15.22% to $39000.0 in 2023, then soared by 87.18% to $73000.0 in 2024, then crashed by 64.38% to $26000.0 in 2025.
  • Its Asset Writedowns and Impairment stands at $26000.0 for Q4 2025, versus $197000.0 for Q3 2025 and $89000.0 for Q2 2025.